If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,082.00    -380.00 (-25.99%)
Bid:
1,092.00
Ask:
1,098.00
Spread: 6.00 (0.549%)
Market Cap: £370.45m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

AGM Statement

8 Nov 2017 07:00

RNS Number : 8493V
Craneware plc
08 November 2017
 

Craneware plc

("Craneware", "the Group" or the "Company")

AGM Statement

 

8 November 2017 - Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, will be holding its Annual General Meeting today at 2pm. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:

 

"We have experienced a positive start to trading in the first four months of the year, adding to the recent announcement of the $6m contract win extending the scope of our solutions within an existing customer. In June, we launched Trisus Claims Informatics, the first product on our cloud-based Trisus platform, to which we have seen a positive market response. In addition, we are seeing very encouraging results for the early adopters of our Trisus Cost Analytics Resource Efficiency product, which is currently under development within Craneware Healthcare Intelligence.

 

"The sales activity and the early product successes demonstrate how we are benefiting from our ongoing investments in our Value Cycle product suite, ensuring we have the solutions that provide insight into key areas of hospital operations, expanding our market opportunity and increasing our strategic value within our market.

 

"Our leadership in this area has further strengthened Craneware's position as a trusted partner for US healthcare organisations as they look to solve the challenges of the new value based reimbursement models.

 

"This positive impact of the Value Cycle on current sales and underlying pipelines combined with the high levels of revenue visibility and significant cash reserves, means we are well positioned to continue to execute on our growth strategy."

 

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

Hilary Buchanan

George Sellar

Robyn Fisher

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBCBDBGGGBGRR
Date   Source Headline
20th May 202512:32 pmRNSForm 8.3 - Craneware plc
20th May 202512:00 pmRNSForm 8.5 (EPT/RI) - Craneware Plc
20th May 202511:41 amRNSForm 8.5 (EPT/RI) - Craneware plc
20th May 202511:27 amRNSForm 8.5 (EPT/NON-RI)-Craneware plc
20th May 202511:09 amRNSForm 8.5 (EPT/RI)-Craneware plc
20th May 20259:59 amRNSForm 8.5 (EPT/RI) - Craneware PLC
20th May 20259:29 amRNSForm 8.3 - Craneware PLC
19th May 20254:23 pmRNSForm 8.5 (EPT/NON-RI)-Craneware plc
19th May 20254:02 pmRNSForm 8.3 - Craneware plc
19th May 20253:20 pmRNSForm 8.3 - Craneware plc
19th May 20253:16 pmRNSForm 8.3 - CRANEWARE PLC
19th May 20252:29 pmGNWForm 8.3 - Craneware Plc
19th May 20252:08 pmBUSForm 8.3 - Craneware PLC
19th May 20251:45 pmGNWForm 8.3 - Craneware plc - Octopus Investments
19th May 20251:43 pmRNSForm 8.3 - Craneware Plc
19th May 20251:42 pmGNWForm 8.3 - [CRANEWARE PLC - 16 05 2025] - (CGAML)
19th May 20251:38 pmGNWForm 8.3 - [CRANEWARE PLC - 16 05 2025] - (CGWL)
19th May 202512:50 pmRNSForm 8.3 - Craneware PLC
19th May 202512:11 pmBUSForm 8.3 - Craneware plc
19th May 202512:00 pmRNSForm 8.5 (EPT/RI) Craneware Plc
19th May 202511:55 amRNSForm 8.3 - Craneware plc
19th May 202511:15 amRNSForm 8.5 (EPT/RI)-Craneware plc
19th May 202511:09 amRNSForm 8.5 (EPT/RI) - CRANEWARE PLC
19th May 202510:31 amRNSForm 8.5 (EPT/RI) - Craneware plc
19th May 20258:57 amGNWForm 8.5 (EPT/RI)-Craneware plc
16th May 20253:16 pmRNSResponse to Statement by Bain Capital
16th May 20251:16 pmRNSForm 8.3 - CRANEWARE PLC
16th May 20259:41 amRNSStatement re Possible Offer
1st May 20253:52 pmRNSHolding(s) in Company
28th Apr 20257:00 amRNSPurchase of Shares by Director and TVR
15th Apr 20257:00 amRNSBlock listing Interim Review
21st Mar 20251:50 pmRNSDividend Currency Election
11th Mar 20257:00 amRNSFY25 Interim Results
19th Feb 20253:23 pmRNSNotification of major holdings
13th Jan 20257:00 amRNSH1 FY25 Trading Update
29th Nov 20244:18 pmRNSDividend Currency Election
20th Nov 20241:57 pmRNSHolding(s) in Company
19th Nov 20245:13 pmRNSVesting of Long Term Incentive Plan Awards and TVR
13th Nov 20241:23 pmRNSResult of AGM
13th Nov 20247:00 amRNSAGM Statement and Board Changes
25th Oct 20243:02 pmRNSHolding(s) in Company
16th Oct 20245:05 pmRNSPosting of Annual Report and Notice of AGM
15th Oct 20247:00 amRNSBlock listing Interim Review
2nd Oct 202412:30 pmRNSTotal Voting Rights
23rd Sep 20245:31 pmRNSHolding(s) in Company
18th Sep 20247:00 amRNSExercise of Share Options
17th Sep 20244:40 pmRNSGrant of Long Term Incentive Plan Awards
12th Sep 20244:50 pmRNSNotification of Major Holdings
11th Sep 20243:45 pmRNSDirector/PDMR Dealings
10th Sep 20247:00 amRNSRelease and discharge of security in the Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.